If you remember Ph3 for Daybue was essential just a rerun of Ph2.
Neu have underway or completed 6 ph2 trials,
Ph3 for these orphan indications will be a walk in the park
Ann: Completion of enrolment in Neuren's Angelman P2 trial, page-18
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.32 |
Change
-0.155(1.07%) |
Mkt cap ! $1.841B | |||
| Open | High | Low | Value | Volume |
| $14.47 | $14.53 | $14.22 | $2.777M | 193.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 219 | $14.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.32 | 1149 | 16 |
View Market Depth
| Last trade - 13.33pm 03/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |